LIM-Pyr1

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameLIM-Pyr1
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionLim kinases inhibitors
TargetsLim kinases
Therapy Area/IndicationsSarcomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellipse SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellipse SAS
Active IndicationsN/A
Inactive IndicationsSarcomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A